Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alfresa HoldingsALFRY 75 Return-on-Tangible-Asset is 2.49% as of Mar. 2026, which is at its 10-year median of 2.49. GuruFocus rates ALFRY with a GF Score™ of 75/100 and a GF Value™ of $16.25 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 118 Medical Distribution companies, Alfresa Holdings ranks better than 54.24% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Alfresa Holdings's annualizedNet Income for the quarter that ended in Mar. 2026 was $246 Mil. Alfresa Holdings's average total tangible assets for the quarter that ended in Mar. 2026 was $9,887 Mil. Therefore, Alfresa Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 2.49%.
The historical rank and industry rank for Alfresa Holdings's Return-on-Tangible-Asset or its related term are showing as below:
ALFRY'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 1.86 Med: 2.49 Max: 3.15
Current: 2.79
During the past 13 years, Alfresa Holdings's highest Return-on-Tangible-Asset was 3.15%. The lowest was 1.86%. And the median was 2.49%.
ALFRY's Return-on-Tangible-Asset is ranked better than 54.24% of 118
companies
in the Medical Distribution industry
Industry Median: 2.34
vs ALFRY: 2.79
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Alfresa Holdings Return-on-Tangible-Asset Related Terms
Alfresa Holdings Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Alfresa Holdings's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ALFRY vs MCK, CAH, COR: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, Alfresa Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alfresa Holdings Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Alfresa Holdings's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 2.49% mean?
Alfresa Holdings (ALFRY) has a Return-on-Tangible-Asset of 2.49% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Alfresa Holdings and its competitors. This is near median its historical median of 2.49. Over the past decade, Alfresa Holdings' Return-on-Tangible-Asset has ranged from 1.86 to 3.15. According to the industry distribution chart, Alfresa Holdings ranks #54 out of 118 companies in the Medical Distribution industry, placing it in the top 45.8%.
Is Alfresa Holdings' Return-on-Tangible-Asset too high?
Alfresa Holdings' current Return-on-Tangible-Asset of 2.49% is near median its 10-year median of 2.49. Over the past 10 years, this metric has ranged from a low of 1.86 to a high of 3.15. The Medical Distribution industry median Return-on-Tangible-Asset is 2.34. Alfresa Holdings' value of 2.49% is 6.4% above this industry median. Based on the distribution chart, Alfresa Holdings ranks #54 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Alfresa Holdings has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' Return-on-Tangible-Asset compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Alfresa Holdings ranks #54 out of 118 companies for Return-on-Tangible-Asset. This puts Alfresa Holdings in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.34. Alfresa Holdings' value of 2.49% is 6.4% above this benchmark. Historically, Alfresa Holdings' own Return-on-Tangible-Asset has ranged from 1.86 to 3.15 over the past decade. While the company's 10-year median is 2.49 vs. the industry median of 2.34, Alfresa Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.34, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alfresa Holdings's current Return-on-Tangible-Asset of 2.49% is 6.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Alfresa Holdings and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alfresa Holdings's current Return-on-Tangible-Asset is 2.49%, which is near median its own 10-year median of 2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (ALFRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.25, compared to a current price of $13.55 — trading 16.6% below its estimated fair value. The current Return-on-Tangible-Asset is 2.49%, which is near median its 10-year median of 2.49 and 6.4% above the Medical Distribution industry median of 2.34. Alfresa Holdings' overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Alfresa Holdings (ALFRY), the current Return-on-Tangible-Asset is 2.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alfresa Holdings (ALFRY) Overvalued in 2026?
Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued.
The current stock price of $13.55 is trading 16.6% below its estimated GF Value™ of $16.25.
GuruFocus considers Alfresa Holdings to be Modestly Undervalued.
Key valuation signals for ALFRY:
Return-on-Tangible-Asset: 2.49% (near median its 10-year median of 2.49)
GF Value™: $16.25 vs. price of $13.55 (16.6% below fair value)
Industry Position: 6.4% above the Medical Distribution median (#54 of 118)
No single metric tells the full story. See the ALFRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
75GF Score
Get the complete analysis for ALFRY
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALFRY has been successfully added to your 
